Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsFrontlines with Frontera, a podcast hosted by neurointensivist Jennifer Frontera, MD, brings you an exclusive interview with Sahar Zafar, MD, MBBS. [LISTEN TIME: 30 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 19, 2025.
GLP-1 research in neurology is on the rise, with several pivotal studies lending insights into their role.
Fear of Movement, Central Sensitization May Worsen Outcomes in Gout
FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026
FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease
Weight-Loss Interventions Improve Psoriasis Severity, Quality of Life
1.
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer
2.
Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.
3.
Basal stem-like cells identified as origin of small cell lung cancer in lab models
4.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
5.
Decrease seen in in situ breast cancer since 2009
1.
The Link Between Being Overweight and Cancer
2.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
3.
Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology
4.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
5.
A Comprehensive Guide To Understanding Plasma Osmolality
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation